March 2022

Dyfan appeals from the District Court’s final judgment of invalidity of asserted patent claims of U.S. Patent Nos. 9,973,899 and 10,194,292  (relating to systems for delivering messages to users based on their locations)…

Hunting Titan petitioned for inter partes review of claims 1–15 of DynaEnergetics’ U.S. Patent No. 9,581,422 which is directed to a perforating gun used in an oil wellbore having a wireless and selective detonator…

Judges Lourie, Moore, and Newman dissent from the denial of Biogen’s petition for rehearing en banc because in their view the panel majority has affirmed a district court’s erroneous broadening of the written…

Commonwealth Scientific and Industrial Research Organization (CSIRO), a research arm of the Australian government, owns six U.S. patents relating to the engineering of plants, particularly canola, to produce specified oils…

U.S. Patent 9,517,219 relates to methods of treating acne or rosacea with dapsone formulations that include a specific thickening agent and solvent, and recites the negative limitation “wherein the topical pharmaceutical composition does…

 Cirrus Design Corp. petitioned for inter partes review of certain claims of U.S. Patent No. RE47,474 relating to aircraft including an intelligent ballistic parachute systems.  Fleming appeals the Board’s final written decision…

Apple appeals from three Board inter partes review (IPR) final written decisions collectively holding Apple failed to show certain claims of U.S. Patent Nos. 9,712,494; 9,712,502; and 9,838,362 would have been obvious. The patents…